Douglas R. Dougan

2.9k total citations
32 papers, 1.6k citations indexed

About

Douglas R. Dougan is a scholar working on Molecular Biology, Genetics and Infectious Diseases. According to data from OpenAlex, Douglas R. Dougan has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Infectious Diseases. Recurrent topics in Douglas R. Dougan's work include Bacterial Genetics and Biotechnology (6 papers), HIV/AIDS drug development and treatment (4 papers) and Enzyme Structure and Function (4 papers). Douglas R. Dougan is often cited by papers focused on Bacterial Genetics and Biotechnology (6 papers), HIV/AIDS drug development and treatment (4 papers) and Enzyme Structure and Function (4 papers). Douglas R. Dougan collaborates with scholars based in United States, Japan and Canada. Douglas R. Dougan's co-authors include Leslie W. Tari, Clifford D. Mol, G. Snell, R.J. Skene, Hua Zou, Daniel Scheibe, Bi‐Ching Sang, T. Schneider, Keith P. Wilson and Michelle L. Kraus and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Douglas R. Dougan

31 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Douglas R. Dougan United States	19	918	378	293	219	152	32	1.6k
R.J. Skene United States	22	1.4k 1.5×	485 1.3×	816 2.8×	203 0.9×	209 1.4×	34	2.5k
Bi‐Ching Sang United States	18	1.2k 1.3×	337 0.9×	711 2.4×	232 1.1×	167 1.1×	30	2.2k
Matthew F. Brown United States	20	596 0.6×	198 0.5×	302 1.0×	118 0.5×	30 0.2×	38	1.5k
Shingo Dan Japan	26	1.4k 1.5×	278 0.7×	493 1.7×	184 0.8×	98 0.6×	95	2.3k
Ciarán N. Cronin United States	22	967 1.1×	115 0.3×	157 0.5×	154 0.7×	63 0.4×	38	1.6k
Swee Y. Sharp United Kingdom	25	2.0k 2.2×	417 1.1×	750 2.6×	100 0.5×	362 2.4×	45	2.8k
John Sensintaffar United States	17	2.0k 2.1×	226 0.6×	424 1.4×	222 1.0×	294 1.9×	29	2.8k
Wynne Aherne United Kingdom	27	1.5k 1.7×	161 0.4×	509 1.7×	110 0.5×	219 1.4×	58	2.3k
Jeffrey Tom United States	16	1.3k 1.4×	218 0.6×	284 1.0×	28 0.1×	75 0.5×	21	1.8k
Maciej Wieczorek Poland	20	831 0.9×	143 0.4×	243 0.8×	84 0.4×	51 0.3×	83	1.4k

Countries citing papers authored by Douglas R. Dougan

Since Specialization

Citations

This map shows the geographic impact of Douglas R. Dougan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas R. Dougan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas R. Dougan more than expected).

Fields of papers citing papers by Douglas R. Dougan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas R. Dougan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas R. Dougan. The network helps show where Douglas R. Dougan may publish in the future.

Co-authorship network of co-authors of Douglas R. Dougan

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas R. Dougan. A scholar is included among the top collaborators of Douglas R. Dougan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas R. Dougan. Douglas R. Dougan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Carney, Daniel W., Michiko Tawada, Jumpei Aida, et al.. (2025). Discovery of Highly Potent Noncovalent Inhibitors of SARS-CoV-2 Main Protease through Computer-Aided Drug Design. Journal of Medicinal Chemistry. 68(20). 21330–21345.

Carney, Daniel W., Abba E. Leffler, Jeffrey A. Bell, et al.. (2024). Exploiting high-energy hydration sites for the discovery of potent peptide aldehyde inhibitors of the SARS-CoV-2 main protease with cellular antiviral activity. Bioorganic & Medicinal Chemistry. 103. 117577–117577. 4 indexed citations

Sabat, M., Haixia Wang, J. David Lawson, et al.. (2017). Design, synthesis and optimization of 7-substituted-pyrazolo[4,3-b]pyridine ALK5 (activin receptor-like kinase 5) inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(9). 1955–1961. 18 indexed citations

Uchiyama, Noriko, Douglas R. Dougan, J. David Lawson, et al.. (2017). Identification of AHCY inhibitors using novel high-throughput mass spectrometry. Biochemical and Biophysical Research Communications. 491(1). 1–7. 9 indexed citations

Gibson, Tony, et al.. (2017). Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy. Bioorganic & Medicinal Chemistry Letters. 27(8). 1709–1713. 15 indexed citations

Cheruvallath, Zacharia S., Christopher M. McBride, Jun Feng, et al.. (2016). Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 1. Bioorganic & Medicinal Chemistry Letters. 26(12). 2774–2778. 12 indexed citations

Wang, Haixia, J. David Lawson, Ruhi Kamran, et al.. (2016). Design, synthesis and optimization of novel Alk5 (activin-like kinase 5) inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(17). 4334–4339. 10 indexed citations

McBride, Christopher M., Zacharia S. Cheruvallath, J. David Lawson, et al.. (2016). Discovery of potent, reversible MetAP2 inhibitors via fragment based drug discovery and structure based drug design—Part 2. Bioorganic & Medicinal Chemistry Letters. 26(12). 2779–2783. 18 indexed citations

Smith, Christopher R., Douglas R. Dougan, Toufike Kanouni, et al.. (2015). Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton’s Tyrosine Kinase. Journal of Medicinal Chemistry. 58(14). 5437–5444. 55 indexed citations

10.

Gangloff, Anthony R., Jason W. Brown, Ron de Jong, et al.. (2013). Discovery of novel benzo[b][1,4]oxazin-3(4H)-ones as poly(ADP-ribose)polymerase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(16). 4501–4505. 28 indexed citations

11.

Hashimoto, Kentaro, Bunnai Saito, Zenyu Shiokawa, et al.. (2013). Design, stereoselective synthesis, and biological evaluation of novel tri-cyclic compounds as inhibitor of apoptosis proteins (IAP) antagonists. Bioorganic & Medicinal Chemistry. 21(18). 5725–5737. 11 indexed citations

12.

Dong, Qing, Douglas R. Dougan, Xianchang Gong, et al.. (2011). Discovery of TAK-733, a potent and selective MEK allosteric site inhibitor for the treatment of cancer. Bioorganic & Medicinal Chemistry Letters. 21(5). 1315–1319. 93 indexed citations

13.

Yamashita, Takashi, Satoshi Endo, Mitsuo Yamamoto, et al.. (2011). Design, synthesis, and structure–activity relationships of spirolactones bearing 2-ureidobenzothiophene as acetyl-CoA carboxylases inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(21). 6314–6318. 16 indexed citations

14.

Wallace, Michael B., Mark E. Adams, Toufike Kanouni, et al.. (2010). Structure-based design and synthesis of pyrrole derivatives as MEK inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(14). 4156–4158. 51 indexed citations

15.

Saitoh, Morihisa, Jun Kunitomo, Eiji Kimura, et al.. (2009). Design, synthesis and structure–activity relationships of 1,3,4-oxadiazole derivatives as novel inhibitors of glycogen synthase kinase-3β. Bioorganic & Medicinal Chemistry. 17(5). 2017–2029. 91 indexed citations

16.

Hosfield, David J., Yanming Zhang, Douglas R. Dougan, et al.. (2004). Structural Basis for Bisphosphonate-mediated Inhibition of Isoprenoid Biosynthesis. Journal of Biological Chemistry. 279(10). 8526–8529. 232 indexed citations

17.

Mol, Clifford D., Douglas R. Dougan, T. Schneider, et al.. (2004). Structural Basis for the Autoinhibition and STI-571 Inhibition of c-Kit Tyrosine Kinase. Journal of Biological Chemistry. 279(30). 31655–31663. 463 indexed citations

18.

Shouldice, Stephen R., Douglas R. Dougan, R.J. Skene, et al.. (2003). High Resolution Structure of an Alternate Form of the Ferric Ion Binding Protein from Haemophilus influenzae. Journal of Biological Chemistry. 278(13). 11513–11519. 29 indexed citations

19.

Shouldice, Stephen R., Douglas R. Dougan, Pamela A. Williams, et al.. (2003). Crystal Structure of Pasteurella haemolytica Ferric Ion-binding Protein A Reveals a Novel Class of Bacterial Iron-binding Proteins. Journal of Biological Chemistry. 278(42). 41093–41098. 23 indexed citations

20.

Vogel, Hans J., et al.. (2000). The structure of the ferric siderophore binding protein FhuD complexed with gallichrome.. Nature Structural Biology. 7(4). 287–291. 103 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact